|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-4-29
|
|
pubmed:abstractText |
Although allergen immunotherapy has been established as a treatment of type I allergy back in 1911, until now the underlying mechanisms have not been fully understood, nor are there any parameters which would allow one to monitor an ongoing treatment or to assess therapeutic success in the meantime.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0954-7894
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
497-506
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10202364-Allergens,
pubmed-meshheading:10202364-Amino Acid Sequence,
pubmed-meshheading:10202364-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:10202364-Female,
pubmed-meshheading:10202364-Humans,
pubmed-meshheading:10202364-Hypersensitivity,
pubmed-meshheading:10202364-Immunoglobulin E,
pubmed-meshheading:10202364-Immunoglobulin G,
pubmed-meshheading:10202364-Male,
pubmed-meshheading:10202364-Molecular Sequence Data,
pubmed-meshheading:10202364-Pollen,
pubmed-meshheading:10202364-Recombinant Proteins
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome.
|
|
pubmed:affiliation |
Forschungszentrum Borstel, Borstel, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
